Remove Drug Delivery Remove Generic Drugs Remove Production
article thumbnail

Eli Lilly Partners with Amazon Pharmacy for Home Delivery of Drugs

XTalks

Lilly’s move is a significant shift in strategy as drugmakers have traditionally steered clear of delivering products to people’s homes or connecting them with healthcare providers. It is estimated that more than 8 million Americans rely on insulin products to manage their diabetes. More than 40 percent of Americans are obese.

Pharmacy 111
article thumbnail

XPhyto Announces Drug Formulation Strategy and 2021 Milestones Innovation to Impact

The Pharma Data

CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (“ XPhyto ” or the “ Company “) is pleased to announce its drug formulation and delivery business strategy and milestones for 2021. Pending positive results, the Company plans to advance the products toward a final pivotal study and application for regulatory approval.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

To List or Not to List; That is the Question – The FTC Signals the Potential for Greater Scrutiny of Patent Information Submissions to FDA

FDA Law Blog

The FTC expressed concern that patent listings that do not meet the statutory criteria undermine the competitive process, may disincentivize investment in developing generic and follow-on products, and reduce patient access to more affordable drugs thereby increasing costs to the healthcare system.

Drugs 105
article thumbnail

Update: FDA clears first generic of AZ’s blockbuster Symbicort

pharmaphorum

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca’s top-selling respiratory drug Symbicort, although launch plans remain uncertain for now. Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1

article thumbnail

XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact

The Pharma Data

Clinical validation of transdermal and sublingual drug formulations. Psychedelic API production, drug formulation and clinical integration. The Company is on the cusp of transformational change as product development programs advance from the laboratory to the clinic. Diagnostics.

article thumbnail

TLC Provides Corporate Update at Investor Conference – Dec 18, 2020

The Pharma Data

In addition, TLC is preparing for scale-up production of TLC590, as for complex lipid products, the manufacturing process and batch size used in pivotal clinical trials and New Drug Application submission must be the same as future commercial batches.

article thumbnail

Valuable Leadership Styles for Pharmaceutical Executives

XTalks

The pharmaceutical industry deals with threats such as product liability, cyberthreats, supply chain disruptions, competition from generic drugs and more. Essentially, they are problem solvers who are always ready to combat challenges with novel solutions. Transformational Leadership.